“Diabetic Nephropathy Epidemiology” report has been added to DelveInsight

 

Overview of Diabetic Nephropathy epidemiology, pathophysiology, various diagnostic approaches, and treatment algorithm, including detailed chapters for marketed products and emerging therapies

 

Download free sample copy- https://www.delveinsight.com/sample-request/diabetic-nephropathy-epidemiology-forecast

 

Diabetic Nephropathy Overview

Diabetic nephropathy is a long-term kidney disease that can affect people with diabetes. It is also known as Diabetic Kidney Disease (DKD). It happens when a person’s kidneys are damaged by elevated blood glucose levels.

 

Diabetic Nephropathy: Geography Covered

• The United States
• EU5 (Germany, France, Italy, Spain, and the United Kingdom)
• Japan

 

Key facts of Diabetic Nephropathy epidemiology report

• As per some of the research studies, diabetic nephropathy develops in approximately 30% of patients with type 1 diabetes mellitus (DM1) and approximately 40% of patients with type 2 diabetes mellitus (DM2) which means that patients with Type 2 diabetes are at a higher risk of developing diabetic nephropathy
• As per a review by Duru et al., 2018, approximately 25% of individuals with diabetes have DKD, and is anticipated to increase by around 52-54% in the coming years, in the United States. In addition to this, Diabetes is responsible for around 30-40% of all end-stage renal disease (ESRD) cases in the United States.
• Diabetic nephropathy is one of the most significant long-term complications. A nation-wide survey in Japan showed that the most common primary cause of renal failure among new dialysis patients was diabetic nephropathy

 

Diabetic Nephropathy Epidemiology Segmentation

• Total prevalent cases of Diabetes (Type 1 and Type 2) in the 7MM [2018–2030]
• Total stage-specific prevalent cases of Diabetic nephropathy in the 7MM [2018–2030]
• Total diagnosed-specific prevalent cases of Diabetic nephropathy (Type 1 and Type 2) in the 7MM [2018–2030]
• Total age-specific prevalent cases of Diabetic nephropathy in the 7MM [2018–2030]
• Treated cases of Diabetic nephropathy in the 7MM [2018–2030]

 

Diabetic Nephropathy Epidemiology Report

Diabetic nephropathy is a leading cause of chronic kidney disease and end-stage renal disease (ESRD). The kidneys in ESRD are no longer able to satisfy the demands of everyday life. Kidney failure can occur as a result of ESRD, which can be life-threatening.

 

Diabetic Nephropathy Risk Factors

The risk factors for diabetic nephropathy incorporate smoking, comorbidities and is more prevalent in people who are more than 62-65 years old. An individual with diabetic nephropathy may not experience any symptoms in the early stages. Changes in blood pressure and fluid equilibrium in the body, on the other hand, may already be present. Waste products can accumulate in the blood over time, causing symptoms. Swollen feet and ankles, darker urine, shortness of breath are some of the symptoms presented in the later stages.

 

Diabetic Nephropathy Treatment

The first step in treating diabetic nephropathy is to monitor and manage diabetes, as well as high blood pressure if necessary (hypertension). Kidney disease and other complications may be avoided or delayed with proper blood sugar and hypertension treatment. Angiotensin-converting enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) can help to lower blood pressure, protect kidney function, and prevent

 

Diabetic Nephropathy Prevalent Population

The prevalence of diabetes worldwide has extended epidemic magnitudes and is expected to affect millions of people in the upcoming years. Diabetic nephropathy is the leading cause of chronic kidney disease (CKD) in the United States and other Western societies. It is also one of the most significant long-term complications in terms of morbidity and mortality for individual patients with diabetes.

 

Diabetic Nephropathy Epidemiology: Report Highlights

• 11-Year Forecast of Diabetic Nephropathy epidemiology
• 7MM Coverage
• Total Cases of Diabetic Nephropathy
• Total Cases of Diabetic Nephropathy according to segmentation
• Diagnosed cases of Diabetic Nephropathy

 

Download free sample copy- https://www.delveinsight.com/sample-request/diabetic-nephropathy-epidemiology-forecast

 

Following is the TOC of Diabetic Nephropathy epidemiology report

1. Key Insights 

2. Executive Summary of Diabetic Nephropathy

3. Diabetic Nephropathy: Disease Background and Overview

4. Patient Journey

5. Epidemiology and Patient Population

6. Treatment Algorithm, Current Treatment, and Medical Practices

7. KOL Views

8. Unmet Needs

9.  Appendix

10. DelveInsight Capabilities

11. Disclaimer

12. AboutDelveInsight

 

What are the reasons to buy this report?

• Develop business strategies by understanding the trends shaping and driving the global Diabetic Nephropathy market
• Quantify patient populations in the global Diabetic Nephropathy market to improve product design, pricing, and launch plans
• Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for Diabetic Nephropathy therapeutics in each of the markets covered
• Understand the magnitude of Diabetic Nephropathy population by its epidemiology
• The Diabetic Nephropathy Epidemiology Model developed by DelveInsight is easy to navigate, interactive with dashboards, and epidemiology based with transparent and consistent methodologies. Moreover, the model supports data presented in the report and showcases disease trends over 11-year forecast period using reputable sources

 

 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Vinita Rakheja
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Albany
State: New York
Country: United States
Website: www.delveinsight.com/